NTRA (STOCKS)
Natera, Inc. Common Stock
$203.500000
+10.470000 (+5.42%)
Prev close: $193.030000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stephen Leonard Chapman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $28,619.79M
- Employees
- 4,434
- P/E (TTM)
- -125.61
- P/B (TTM)
- 15.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.31B |
| Benefits Costs and Expenses | $2.57B |
| Costs And Expenses | $2.62B |
| Operating Expenses | $2.62B |
| Selling, General, and Administrative Expenses | $1.18B |
| Research and Development | $624.11M |
| Other Operating Expenses | $814.65M |
| Operating Income/Loss | -$309.91M |
| Income/Loss From Continuing Operations After Tax | -$208.16M |
| Income/Loss From Continuing Operations Before Tax | -$268.09M |
| Income Tax Expense/Benefit | -$59.93M |
| Interest Expense, Operating | $4.07M |
| Net Income/Loss | -$208.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$208.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$208.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.52 |
| Diluted Earnings Per Share | -$1.52 |
| Basic Average Shares | 136,721,000 |
| Diluted Average Shares | 136,721,000 |
| Assets | $2.40B |
| Current Assets | $1.50B |
| Inventory | $68.44M |
| Other Current Assets | $1.43B |
| Noncurrent Assets | $901.41M |
| Fixed Assets | $241.18M |
| Intangible Assets | $373.71M |
| Other Non-current Assets | $286.51M |
| Liabilities | $685.93M |
| Current Liabilities | $441.23M |
| Accounts Payable | $33.16M |
| Wages | $92.60M |
| Other Current Liabilities | $315.47M |
| Noncurrent Liabilities | $244.70M |
| Equity | $1.71B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.71B |
| Liabilities And Equity | $2.40B |
| Net Cash Flow From Operating Activities | $215.30M |
| Net Cash Flow From Operating Activities, Continuing | $215.30M |
| Net Cash Flow From Investing Activities | -$132.21M |
| Net Cash Flow From Investing Activities, Continuing | -$132.21M |
| Net Cash Flow From Financing Activities | $47.46M |
| Net Cash Flow From Financing Activities, Continuing | $47.46M |
| Net Cash Flow | $130.55M |
| Net Cash Flow, Continuing | $130.55M |
| Comprehensive Income/Loss | -$208.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$208.07M |
| Other Comprehensive Income/Loss | $86.00K |